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1. Introduction    
Cells are continually exposed to genotoxic stresses. Upon DNA damage, the cell activates a 
coordinated and complex series of responses (Levitt and Hickson, 2002). Multiple factors are 
implicated in each of these responses. Recently, it has become apparent that various 
transcription factors play important roles in cellular responses to genotoxic stress. In 
particular, E2F transcription factors are key for the activation of genes involved in these 
processes. 
E2F family comprises two subfamilies, termed E2F and DP, and includes orthologs 
expressed across many species, from plants to higher vertebrates (McClellan and Slack, 
2007). In mammals, multiple E2F (E2F-1 through -8) and DP (DP-1 through -4) genes have 
been identified. E2F-1, -2 and -3 are associated with DNA synthesis and cell cycle 
progression, and function as heterodimers with a DP member (McClellan and Slack, 
2007). E2F-4 and -5 also require association with a DP protein, but often function to halt 
cell cycle progression associated with terminal differentiation or reversible entry into 
quiescence (McClellan and Slack, 2007). E2F-1 through -5 can mediate transcriptional 
activation when found as ȸfreeȹ E2F/DP dimers, but can also act as transcriptional 
repressors if they are associated with a member of the retinoblastoma (pRb) family of 
proteins (Hallstrom and Nevins, 2009). In contrast, E2F-6 lacks both transcriptional 
activation and pRb-binding domains, and functions as a constitutive transcriptional 
repressor. The most divergent members of the E2F family are E2F-7 and -8, which bind 
neither DP nor pRb-family proteins, and also function as transcriptional repressors to 
mediate cell cycle arrest (Lammens et al., 2009). To regulate gene expression, E2F factors 
bind GC-rich elements on proximal promoters, which can conform to either a consensus 
5’-TTTC[CG]CGC-3’ element, or to non-consensus sequences (Judah et al., 2010; 
Rabinovich et al., 2008). Considerable efforts have been directed to investigate whether 
different E2F proteins exhibit target selectivity. Genome-wide screens for E2F targets have 
revealed considerable overlap in the ability of individual E2F proteins to regulate their 
targets, although a few promoters activated by specific E2F forms have been identified 






In spite of the vast similarities in the activities of distinct E2F proteins and their ability to bind 
potential target Genes, to-date E2F1 is the principal E2F member shown to participate in 
cellular responses to DNA damage (Bracken et al., 2004). The role of E2F-1 upon DNA damage 
depends on cellular context. E2F-1 can either induce pro-apoptotic or anti-apoptotic outcomes. 
During the latter, E2F-1 can play roles to induce cell cycle arrest and upregulate DNA repair, 
by directing expression of multiple genes. These genes are involved in mismatch repair 
(MSH2, MLH1), nucleotide excision repair (DDB2, RPA), homologous recombination repair 
(RAD51, RAD54, RECQL), base excision repair (UNG, APE) & non-homologous end joining 
(Chang et al., 2006; Ishida et al., 2001; Polager and Ginsberg, 2008; Prost et al., 2007). 
In humans, E2F-1 is a 437 amino acid protein, which shows constitutive and rapid 
nucleocytoplasmic shuttling in a variety of cells (Ivanova et al., 2007).  E2F-1 stimulates cell 
proliferation by positively modulating transcription of genes necessary for DNA synthesis 
and cell cycle progression (Ivanova et al., 2005). In an apparently paradoxical manner, E2F-1 
can also induce cell cycle arrest when associated with pRb, or apoptosis, by activating 
expression of pro-apoptotic genes (Polager and Ginsberg, 2008).  The breadth of E2F-1 
targets mediates the distinct biological activities of this transcription factor, which 
encompass both oncogenic and anti-oncogenic properties, as well as positive modulation of 
tissue regeneration after injury (D'Souza et al., 2002; Field et al., 1996). 
2. E2F-1 and the DNA damage response 
Genotoxic stress in cells activates the DNA damage response, and can occur as a result of a 
variety of insults. The latter include DNA double- strand breaks and single-strand damage. 
DNA damage can result from exogenous agents (e.g. radiation, exposure to reactive and 
mutagenic chemicals), or from endogenous products of cell metabolism (Shiloh, 2003). In 
response to DNA damage, cells activate multiple pathways that result in apoptosis or in 
DNA repair, cell cycle arrest, changes in gene expression, as well as in protein synthesis and 
degradation.  
Cells require efficient response mechanisms to genotoxic stress, as this is a life-threatening 
event because it can significantly alter their genetic material. Multiple mechanisms have 
evolved to repair damage induced by genotoxic stress, including activation of a global 
signalling network termed the DNA damage response (DDR), which is capable of detecting 
distinct types of DNA damage, coordinating appropriate responses. The latter include 
transcriptional activation, cell cycle arrest, apoptosis, senescence and DNA repair (Shiloh, 
2003). The DNA damage response plays a critical role in cell survival when damage occurs 
during DNA replication. In addition, there are specialized processes, including base-
excision repair (BER), nucleotide-excision repair (NER) & nonhomologous end-joining, 
which recognize and repair specific types of lesions (Shiloh, 2003). Central to transduce 
signals that indicate DNA damage and initiate appropriate cellular responses are two 
related protein kinases, termed ATM (ataxia telangiectasia mutated) and ATR (ATM and 
Rad3-related). ATM can associate with its regulator, the MRN (Mre11-Rad50-NMS1) 
complex, when double-strand breaks (DSB) are generated (Levitt and Hickson, 2002). On the 
other hand, ATR forms complexes with its regulator ATRIP (ATR-interacting protein), 
which senses single-strand DNA (ssDNA) breaks generated by processing of double-strand 
breaks, as well as single-strand DNA which arises from stalled replication forks (Shiloh, 
2003). These two kinases also phosphorylate E2F-1, thus initiating transcriptional activation 
of its target DNA repair genes. 
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2.1 Identification of E2F targets involved in DNA damage repair 
Central to understanding the role of the E2F family of transcription factors in DNA repair 
has been the identification of a large number of putative and demonstrated E2F target genes. 
Although E2F proteins were originally characterized as important regulators of cell cycle 
progression, genome-wide screens have demonstrated much broader roles in a variety of 
primary and immortalized cell types. For example, E2F-1 and E2F-3 bind to the promoters of 
apurinic/apyrimidinic endonuclease (APE) and other repair enzymes in human primary 
epidermal keratinocytes, irrespective of their differentiation status (Chang et al., 2006). 
Similarly, in the GM06990 lymphoblastoid cell line, non-biased genome-wide screening has 
identified a large number of putative E2F-4 targets involved in responses to DNA damage 
(Lee et al., 2011). E2F targets important for DNA repair have also been identified in 
neoplastic cells following therapeutic intervention. For example, treatment of prostate 
cancer cells with histone deacetylase inhibitors reduces their ability to repair DNA damage 
induced by radio- and chemotherapy, thus reducing tumour mass (Kachhap et al., 2010). 
The impaired ability to repair DNA of treated cells was due, at least in part, to decreased 
recruitment to and activation by E2F-1 to the promoters of key DNA repair genes. Hence, 
the importance of E2F factors in DNA repair encompasses not only events during 
carcinogenesis, but also the potential impact of various therapies. 
2.2 Role of E2F-1 in responses to DNA damage induced by UV radiation 
UV radiation induces severe DNA damage, which is the principal cause of skin 
carcinogenesis in humans (Brash et al., 1996). UV-B radiation induces formation of 
cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) pyrimidone photoproducts (6-
4PP), which would result in loss of DNA integrity and genetic instability if left unrepaired. 
This type of damage to DNA triggers activation of the nucleotide-excision repair pathway, 
and can occur via one or more streams. Such DNA repair streams include (i) global genome 
repair (GGR), which repairs damage from the entire genome, (ii) transcription-coupled 
repair (TCR), which generally repairs damage on actively transcribed DNA strands & (iii) 
transcription domain-associated repair (DAR), which deals with repairing both strands of 
actively transcribed regions (Nouspikel, 2009).  
Normal responses of the epidermis to UV damage are critically dependent on E2F-1 
expression. Indeed, increased levels of epidermal apoptosis upon UV-B irradiation have 
been reported in E2F-1-null mouse epidermis, whereas repair of UV-B-induced DNA 
photoproducts is more efficient in keratinocytes that overexpress E2F-1 (Berton et al., 2005). 
UV-induced DNA damage results in stabilization of E2F-1 protein, which stimulates 
nucleotide excision repair (Berton et al., 2005; Pediconi et al., 2003; Wikonkal et al., 2003). 
The mechanisms involved include phosphorylation of E2F-1 on Ser31 by ATR and/or ATM 
kinases (Lin et al., 2001). This modification facilitates E2F-1 recruitment to sites of double-
strand breaks or UV-induced DNA damage. Under these conditions, E2F-1 interacts with 
two key proteins involved in DNA repair: TopBP1 and GCN5 histone acetyltransferase (Guo 
et al., 2010a; Guo et al., 2010b). Formation of these E2F-1 complexes is necessary for efficient 
recruitment of factors involved in nucleotide excision repair. Importantly, the association of 
E2F-1 with TopBP1 and GCN5 occurs at the expense of the E2F-1-induced expression of pro-
apoptotic p73, thus ensuring that DNA repair, rather than apoptosis, takes place (Berton et 
al., 2005; Pediconi et al., 2003; Wikonkal et al., 2003).  In mouse embryo fibroblasts, UV-C 
irradiation results in the formation of both CPD and 6-4PP. In these cells, nucleotide excision 






(XPC) gene expression by E2F-1 via increased binding to the XPC promoter (Lin et al., 2009). 
XPC is an essential mediator of DNA damage recognition during global genomic repair, and 
this phase of repair is actually more efficient in pRB-deficient cells, likely because lack of 
pRb increases E2F-1 activity. 
The importance of E2F in repair of DNA damage induced by UV radiation is further 
demonstrated by the conservation of this pathway through evolution. For example, in 
Arabidopsis and in maize, MSH2 and MSH6, which are two genes that belong to the 
mismatch repair system, are targets of E2F transcriptional activation following DNA 
damage by UV-B radiation (Lario et al., 2011). 
2.3 E2F is a key factor to maintain the balance between cell cycle arrest and 
expression of DNA repair genes following DNA damage  
Given the key roles that pRb family proteins play in the regulation of E2F activity, it is not 
surprising that they also modulate the function of E2F factors following DNA damage. For 
example, the zinc finger-containing transcriptional repressor ZBRK1 is an important 
modulator of GADD45A transcription. The latter is involved in induction of cell cycle arrest 
in response to DNA damage (Siafakas and Richardson, 2009). E2F-1, but not other E2F 
proteins, binds to the ZBRK1 promoter, together with pRb, CtIP and CtBP, forming 
repressor complexes that interfere with ZBRK1 expression (Liao et al., 2010). In pRb-
deficient cells, increased susceptibility to DNA damage induced by UV radiation or 
methylating agents occurs, partly as a result of abnormal cell cycle arrest and DNA repair. 
In a similar manner, E2F-1 is essential for normal expression of XRCC1 (x-ray repair cross-
complementation group 1), which participates in the repair of single-strand breaks, thus 
ensuring efficient repair following DNA damage induced by methylating agents (Chen  
et al., 2008). 
In contrast, loss of pRb can improve DNA repair in other circumstances, such as those 
involving activation of DDB2. Mutations in the DDB2 gene, which encodes a protein 
involved in global genomic repair and repair of CPDs, gives rise to xeroderma 
pigmentosum, a disorder associated with increased risk of cutaneous and ocular tumours 
(Bennett and Itoh, 2008). DDB2 expression is positively regulated by E2F-1 and E2F-3. 
Further, deletion of pRb increases DDB2 mRNA and protein levels, together with ability of 
these cells to repair DNA damage. The latter is associated with more efficient CPD removal 
relative to that in pRb-expressing cells (Prost et al., 2007). 
Solid tumours frequently exhibit hypoxic cores, which contribute to genetic instability 
within the tumour microenvironment (Bindra et al., 2005). This is partly due to decreased 
expression of DNA mismatch genes (MLH1 and MSH2), as well as repair genes (RAD51 
and BRCA1). E2F factors can also be involved in the downregulation of some of these 
repair genes, in apparent contrast to their pro-repair roles in other circumstances. 
Specifically, hypoxic conditions result in the dephosphorylation of the pRb family 
member p130, which then associates with E2F-4 in the nucleus. This complex can 
efficiently bind to E2F sites on the RAD51 and BRCA1 promoters, thus interfering with 
their transcription (Bindra et al., 2005). Thus, E2F factors can positively or negatively 
regulate DNA repair, depending on cellular context. Given that E2F-4/p130 complexes 
are also important for cell cycle exit, a balance must exist between these two outcomes, 
which is essential to avoid increased genetic instability in transformed cells and their 
clonal expansion. 
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2.4 Role of E2F-1 in senescence-associated DNA damage  
Senescence is defined as irreversible cell cycle arrest, which occurs both in cultured cells and 
in vivo (Lanigan et al., 2011). Senescence has been recognized as a key mechanism that acts 
as a barrier to tumour formation and progression. Thus, in spite of any DNA damage that 
may exist in a long-lived cell, if this cell is senescent it will not undergo clonal expansion to 
generate daughter cells with altered DNA. A number of molecular mechanisms control 
cellular senesce, and the E2F/pRb pathway is a key component (Lanigan et al., 2011). Under 
normal circumstances, the frequency of DNA mutations increases with age. DNA mismatch 
mutation repair is very efficient in mesenchymal cells from young individuals, as well as in 
embryonic fibroblasts (Chang et al., 2008). In contrast, these mechanisms are less efficient in 
senescent cells, in which MSH2 expression is decreased. Associated with these abnormalities 
is the inhibition of E2F-1 transcriptional activity, which leads to repression of MSH2 gene 
transcription. Thus, E2F-1 activity is essential to maintain normal capacity of cells to repair 
mismatch mutations. Whether the reduced activity of E2F-1 also increases the risk of 
transformation in senescent cells probably depends on cell context, extent of DNA damage, 
and presence of other oncogenic stimuli.  
2.5 Role of E2F/DP interactions in DNA repair  
The interactions between E2F-1 through -6 and their partner DP proteins are essential for 
normal transcriptional activity, and can also contribute to abnormal regulation of DNA 
repair factors. Again, depending on the exact context, E2F/DP interactions can positively 
or negatively modulate DNA repair. For example, following DNA damage by a variety of 
agents, including doxorubicin, etoposide and UV radiation, the abundance of DP-4 
protein is substantially increased, replacing other DP proteins in E2F-1-containing 
complexes  (Ingram et al., 2011). As a result, the capacity of E2F-1 to bind target promoters 
is strongly reduced, which can result in downregulation of cell cycle regulatory and/or 
DNA repair genes.  
A positive modulatory role in DNA nucleotide excision repair through inhibition of 
repressor E2F complexes has been recently attributed to p14Arf (Dominguez-Brauer et al., 
2009).  Specifically, DNA damage induces p14Arf expression, which directly binds to DP-1, 
disrupting its interactions with E2F-4. As a result, repressive E2F-4/p130 complexes lose 
their ability to bind promoters of genes such as XPC, resulting in upregulation of their 
expression. 
To-date, multiple mechanisms that regulate E2F-1 activity at the post-transcriptional level 
have been identified, although only a handful has been studied in the context of DNA 
repair. These forms of regulation of E2F-1 activity can have important consequences on its 
ability to modulate DNA damage responses, as discussed below. 
3. Role of miRNAs in E2F regulation of cell growth and DNA repair 
MicroRNAs (miRNAs) are short nucleotide sequences (~21-24nt) that pair with the 3’-
untranslated regions of target mRNAs. They negatively regulate gene expression by 
mediating degradation of the target mRNA, or by inhibition of protein translation (Almeida 
et al., 2011). Small miRNAs regulate many cellular processes, such as apoptosis, 
differentiation, and proliferation. They are upregulated in many human disorders, including 
cancer and neurological diseases (Almeida et al., 2011). To-date, approximately 800 miRNAs 






Jones, 2004). Consistent with their role in cancer, miRNAs control cell proliferation by 
regulating E2F factors and, thereby, expression of genes that are important for cell cycle 
progression. 
The E2F signalling pathway is regulated by many different types of miRNA clusters, 
including miRNA-17-92, miRNA-106b-25, miRNA-34, miRNA330-3p, miRNA-128, miRNA-195, 
miRNA-37 and miRNA-193a, as described below.  
3.1 Growth-promoting miRNAs 
O’ Donnell et al. were the first to provide evidence that E2F is a target for miRNAs 
(O'Donnell et al., 2005). They showed that miRNA-17 and miRNA-20a decrease E2F-1 
translation efficiency. This type of regulation prevents uncontrolled activation of E2F-1 
during normal cell cycle progression. Disruption of miRNA-17 and miRNA-20a leads to 
improperly timed expression of E2F-1, resulting in the accumulation of DNA double strand 
breaks (Pickering et al., 2009).  
An auto-regulatory loop between E2F-1 and E2F-3 and the miRNA-17-92 clusters has been 
demonstrated. E2F-1 and E2F-3 bind to and upregulate the transcription of the miRNA-17-
92 cluster. In turn, the miRNA-17-92 cluster downregulates expression of these two 
transcription factors (Sylvestre et al., 2007; Woods et al., 2007). This negative feedback loop 
is important to prevent the accumulation of E2F-1 and E2F-3, thereby allowing proper 
progression of the cell cycle, preventing apoptosis. Another negative feedback loop has been 
observed between the miRNA-106b-25 clusters and E2F-1 (Petrocca et al., 2008). miRNA106b 
and miRNA93 downregulate E2F-1 expression. Reciprocally, transcription of these miRNAs 
is activated by E2F-1. In this manner, properly timed expression of E2F-1 during the G1/S 
transition is maintained, as the presence of these miRNAs prevents continuous E2F-1 
expression throughout the cell cycle, which would induce apoptosis. 
3.2 Tumor suppressor miRNAs  
The E2F signalling pathway is also regulated by the miRNA-34 family of clusters (Tazawa et 
al., 2007). miRNA-34b decreases E2F-1 and E2F-3 transcript levels in a p53-dependent 
manner, inhibiting cell proliferation and inducing senescence in tumour cells. This 
demonstrates that miRNAs can function as tumor suppressors.  A similar role has been 
suggested for miRNA-195 (Xu et al., 2009), miRNA-128 (Cui et al., 2010), miRNA-330-3p 
(Lee et al., 2009) and miRNA193a (Kozaki et al., 2008).  
Overexpression of miRNA-195 causes cell cycle arrest at the G1/S boundary, by interfering 
with the expression of cell cycle regulatory proteins, such E2F-3, Cyclin D1 and cyclin-
dependent kinase 6 (CDK6).  As a result, pRb remains hypophosphorylated, allowing 
activation of E2F-dependent target genes (Xu et al., 2009). Exogenous expression of miRNA-
127 in glioma cells represses E2F-3a translation, thereby decreasing cell proliferation (Cui et 
al., 2010). Similarly, in oral squamous cell carcinoma, miRNA193a significantly represses cell 
growth and down-regulates E2F-6 translation (Kozaki et al., 2008).  
3.3 Role of miRNAs in modulation of DNA repair by E2F-1 
Several miRNA clusters, including mir17-92, mir-106a-92 and mir106b-25, are downregulated 
by p53 via E2F-dependent mechanisms. This leads to decreased proliferation and/or 
promotes senescence in normal and transformed cells (Brosh et al., 2008). In addition, in 
response to mitogenic stimulation, E2F-1 activates transcription of the miRNA clusters let-
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7a-d, mir-15b-16-2 and mir-106b-25 during the G1/S transition (Bueno et al., 2010). These 
miRNAs, in turn, regulate E2F-1 activity. In their absence, E2F-1 induces entry into S phase, 
but also DNA damage. Indeed, E2F-1 and other oncogenes can induce stalling and 
collapsing of DNA replication forks, leading to the formation of DNA double-strand breaks 
(Halazonetis et al., 2008). Thus, let-7a-d, mir-15b-16-2 and mir-106b-25 play key roles in 
prevention of DNA damage and replicative stress associated with abnormal regulation of 
E2F-1 (Zhang et al., 2011). 
4. Regulation of E2F-1 by post-translational modifications 
Another mode of E2F regulation that fine-tunes cell cycle progression and DNA repair 
occurs at the post-translational level. Post-translational modifications identified in E2F-1 
include phosphorylation, acetylation, methylation & ubiquitination. These modifications can 
exert either activating or inhibitory effects on E2F-1 transcriptional activity.  
4.1 Acetylation 
E2F-1 is acetylated at three highly conserved lysine residues (K117, K120 and K125) by the 
p300/CREB-binding protein (CBP) or by p300/CBP-associated factor (P/CAF) 
acetyltransferase (Martinez-Balbas et al., 2000; Marzio et al., 2000).  P/CAF directly interacts 
with E2F-1 through its adenosine deaminase 2 (ADA2) binding domain (Martinez-Balbas et 
al., 2000). Acetylation of E2F-1 allows for marked stabilization and significant increase in 
E2F-1 protein levels. This leads to an increase in transcriptional activation of E2F-1 target 
genes (Farhana et al., 2002; Martinez-Balbas et al., 2000).  
Increases in E2F-1 protein levels upon DNA damage are partly due to cell type-specific 
acetylation (Blattner et al., 1999; Meng et al., 1999; Zhu et al., 1999). For example, 
adriamycin-mediated treatment induces E2F-1 acetylation in human glioblastoma T98G cells 
(Pediconi et al., 2003) , but not in HeLa cells (Ozaki et al., 2009). In response to DNA 
damage, E2F-1 switches to activate pro-apoptotic gene expression, rather than cell cycle 
progression. This change requires E2F-1 acetylation and recruitment to promoters of pro-
apoptotic target genes, such as p73 (Pediconi et al., 2003). P/CAF, but not p300, is required 
for E2F-1 stabilization upon DNA damage by doxorubicin (Ianari et al., 2004). On the other 
hand, overexpression of p300 can be sufficient for acetylation and stabilization of E2F-1 in 
cells treated with camptothecin, a drug that causes double strand break during DNA 
replication (Galbiati et al., 2005). The distinct actions of these two acetyltransferase can thus 
determine the outcome of cellular responses by modulating cellular DNA damage 
checkpoints (p300) or apoptotic events (P/CAF). The stabilization of E2F-1 by acetylation 
could also allow it to directly interact with activating signal cointegrator-2 (ASC-2), a 
mitogenic transcription factor co-activator that regulates cellular proliferation and cell cycle 
progression (Kong et al., 2003). 
4.2 Phosphorylation 
E2F-1 is phosphorylated on several residues, giving rise to modifications that can alter 
different functional aspects.  E2F-1 was first identified as a substrate for phosphorylation in 
a cell-free system (Bagchi et al., 1989). This post-translational modification interfered with 
E2F-1 DNA binding activity. Consistent with these observations, E2F-1 and E2F-3 showed 
decreased DNA binding capacity upon phosphorylation by cyclin A-activated cyclin-






cyclin A, cdk2, E2F-1, and DP-1 are formed during Late S-phase to terminate E2F-dependent 
DNA binding and transcription, and enable orderly S-phase progression (Krek et al., 1995). 
In the absence of cyclin A-cdk2 activity, there is decreased E2F-1 phosphorylation and 
increased DNA binding activity (Li et al., 1997). This results in S-phase delay and/or arrest, 
by mechanisms that involve transcriptional activation of E2F-dependent cell cycle 
checkpoint genes.  Together, these data demonstrate that E2F-1 phosphorylation is essential 
for timely activation of E2F-1 function and orderly cell cycle progression and survival. A 
second proline-directed kinase, c-Jun N-terminal protein kinase (JNK1),  can phosphorylate 
E2F-1 in response to stress stimuli mediated by tumor necrosis factor-alpha, decreasing its 
ability to bind DNA and activate target gene transcription (Kishore et al., 2003).   
Following DNA damage, Chk2 and ATM phosphorylate E2F-1 on Ser364 and Ser31, 
respectively (Lin et al., 2001). E2F-1 phosphorylated on Ser31 subsequently interacts with 14-
3-3τ (Wang et al., 2004).  This interaction prevents E2F-1 association with the SKP1-Cullin-F-
box/ S-phase kinase-associated protein 2 (SCFSkp2) ubiquitin ligase. As a result, E2F-1 is not 
ubiquitinated and is protected from degradation. The net result of phosphorylation of E2F-1 
at Ser31 and Ser364 after DNA damage is activation of the pro-apoptotic gene p73, as well as 
accumulation of p53 through upregulation of p19ARF expression. The latter protein inhibits 
ubiquitination and degradation of p53, inducing apoptosis (Weber et al., 1999). In additon, 
the ATM and Chk2 promoters are activated by E2F-1, thereby forming a positive feedback 
pathway that promotes apoptosis (Berkovich and Ginsberg, 2003) .  
The phosphorylation of E2F can also affect its ability to interact with other proteins.  In 
Drosophila melanogaster, phosphorylation of E2F-1 and E2F-2 enhances their ability to interact 
with the SCFslmb ubiquitin ligase complex, targetting it for degradation during S phase 
(Heriche et al., 2003).  In vitro, E2F-1 is phosphorylated at Ser337 by complexes containing 
p34cdc2 and cyclin B (Dynlacht et al., 1997). The significance of this finding is not clear, as 
E2F-1 phosphorylation on these residues occurs during late G1 phase, and is mediated by 
cyclin D-cdk4 complexes (Mann and Jones, 1996). Phosphorylation of E2F-1 at Ser332 and 
Ser337 enhances E2F-1 interactions with the adenovirus E4 protein, simultaneously 
attenuating its ability to bind pRb (Fagan et al., 1994). Upon adenovirus infection, the 
enhanced interaction between E2F-1 and E4 increases the efficiency of E2A transcription, 
which is required for viral DNA replication (Hardy et al., 1989). 
Changes in phosphorylation status also modulate the activity and subcellular localization of 
E2F-4 and E2F-5, although these changes are unlikely to be mediated by cyclin A-dependent 
cdk activity (Dynlacht et al., 1997). Regulation of E2F-4 and E2F-5 by phosphorylation is 
important during entry into quiescence associated with cell differentiation, but varies 
depending on the cell type. For example, hypophosphorylated forms of E3F-4 efficiently 
associate with p130 in the nucleus, forming transcriptional repressor complexes associated 
with growth arrest in muscle cells (Shin et al., 1995). In contrast, in human intestinal crypt 
cells, hypophosphorylated E2F-4 is imported into the nucleus in response to mitogenic 
stimuli or inhibition of p38 MAP kinase, where it activate genes necessary for S phase entry 
(Deschenes et al., 2004).  
E2F-5 is phosphorylated by cyclin E/cdk2 complexes on Thr251 in the transcriptional 
activation domain, stimulating cell cycle progression (Morris et al., 2000). This modification 
stabilizes E2F-5 interaction with the co-activator p300/CBP, resulting in transcription of 
genes required for DNA synthesis. Significantly, phosphorylation of E2F-5 at Thr251 does 
not affect its DNA binding activity, intracellular localization or ability to interact with pRb 
family proteins.   
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In epidermal keratinocytes, E2F-1 is tightly regulated during normal proliferation and 
differentiation (Ivanova and Dagnino, 2007; Ivanova et al., 2009; Wong et al., 2003). E2F-1 is 
localized in the nucleus in undifferentiated keratinocytes, but differentiation induces its 
export to the cytoplasm, where it is degraded. The signaling pathways involved in E2F-1 
turnover in differentiating keratinocytes involve activation by Ca2+ of protein kinase C eta 
and delta, followed by activation of p38β. The latter appears to phosphorylate E2F-1 at 
Ser403 and Thr433. Once E2F-1 is phosphorylated, it is exported from the nucleus in a 
CRM1-dependent fashion, and degraded in the proteasome. This sequence of events 
involving E2F-1 phosphorylation, ubiquitination, nuclear export and subsequent 
degradation is required for proper keratinocyte differentiation (Ivanova et al., 2006; Ivanova 
and Dagnino, 2007; Ivanova et al., 2009).  
E2F-1 degradation subsequent to phosphorylation also occurs in HeLa cells. Specifically, 
phosphorylation of E2F-1 at Ser403 and Thr433 by TFIIH-cdk7 targets E2F-1 for degradation 
during S phase (Vandel and Kouzarides, 1999). Phosphorylation at Ser403 is also induced 
upon DNA damage (Real et al., 2010). Ser403 and Thr433 in E2F-1 are also phosphorylated 
by glycogen synthase kinase-3β (GSK3β) in HEK293T cells (Garcia-Alvarez et al., 2007). In 
U2OS osteosarcoma cells treated with doxorubicin, Ser403 is phosphorylated, but is not a 
substrate of either p38 MAP or GSK3β kinases (Real et al., 2010). Under these conditions, 
phosphorylation of Ser403 results in changes in E2F-1 target selectivity. Thus, the 
mechanisms and consequences of E2F-1 phosphorylation on Ser403 appear to be cell-type 
and context dependent (Ivanova et al., 2009).  
4.3 Methylation 
Lysine methylation plays critical regulatory roles for histones and non-histone proteins 
(Huang et al., 2008).  The consequences of methylation on E2F-1 activity are controversial at 
present. E2F-1 is methylated by Set9, a histone H3 methyltransferase, at Lys185, both in vitro 
and in cultured cells (Kontaki et al., 2010, Xie et al., 2011). It has been reported that DNA 
damage in p53-deficent H1299 lung carcinoma cells is associated with loss of E2F-1 
methylation by the lysine-specific demethylase 1(LSD1). Demethylation stabilizes E2F-1, 
allowing its upregulation of p73. Importantly, methylation of E2F-1 at Lys185 impairs its 
acetylation and phosphorylation on Ser364, targeting E2F-1 for ubiquitination and 
degradation in doxorubicin-treated cells (Kontaki et al., 2010). In stark contrast, methylation 
of E2F-1 at Lys185 by Set9 in U2OS and HCT116 cells treated with adriamycin resulted in 
E2F-1 stabilization and cell apoptosis (Xie et al., 2011). The reasons for these pronounced 
discrepancies are not clear. 
4.4 Ubiquitination 
Many studies have shown that the expression of E2F-1 is regulated by the ubiquitin 
proteasome pathway, and that E2F-1 is protected from degradation by binding to pRb 
(Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996). In 
mammalian and plant cells, E2F-1 is regulated at the S/G2 phases of the cell cycle through 
ubiquitination by the SCFSKP2-dependent pathway (del Pozo et al., 2002; Marti et al., 1999). In 
vitro, ROC-cullin ligase ubiquitinates E2F-1 in a Skp2-independent manner. Further, 
phosphorylation of E2F-1 by cyclin A/cdk complexes does not affect E2F-1 ubiquitination 
(Ohta and Xiong, 2001). Another E3 ubiquitin ligase complex, the anaphase-promoting 






al., 2010). The presence of multiple E3 ligases that interact with and mediate degradation of 
E2F-1 enables orderly control of E2F-1 expression under multiple circumstances. 
5. Regulation of E2F activity by protein-protein interactions 
The first type of protein-protein interactions shown to modulate E2F transcriptional activity 
included association with the retinoblastoma family of proteins (pRB, p107 and p130). pRB 
is a key regulator of E2F-1, -2 and -3 activity and G1/S-phase transition (Weintraub et al., 
1995).  The importance of pRb regulation of E2F is evidenced by the fact that a majority of 
human tumours exhibit inactivating alterations in the pRb pathway (Nevins, 2001). 
Subsequent studies have revealed thet E2F forms complexes with a multitude of additional 
proteins, underlining the levels of complexity of E2F regulation. 
Protein-protein interactions also appear to assist or provide target specificity to E2F under 
certain conditions. This effects appear to involve cooperative interactions between E2F and 
other transcription factors, mediated by binding to neighbouring consensus sites on target 
promoters.  Consensus binding sites for various transcription factors have been identified in 
the promoters of a subset of E2F target genes. These sites are generally adjacent to the E2F 
binding sites, and include recognition sequences for YY1, TFE3, and C/EBPα (Schlisio et al., 
2002; van Ginkel et al., 1997). These sites possess biological significance, and assist E2F in 
binding to its consensus sequence. This determines the specific phase of the cell cycle in 
which E2F activates such promoters. In addition, as these other transcription factors do not 
interact equally well with all E2F members, they constitute a mechanism of activation of 
individual E2F factors (Giangrande et al., 2003; Schlisio et al., 2002). 
5.1 Retinoblastoma family proteins 
pRb binds predominantly to E2F-1, E2F-2, and E2F-3, blocking their transactivation domains 
(Flemington et al., 1993; Xiao et al., 2003). Under certain circumstances, such as during 
responses to transforming growth factor-beta in certain cell lines, pRb also binds E2F-4 and 
represses transcription (Yang, et al. 2008). The pRb family of proteins can also repress 
transcription of E2F target genes by recruiting other factors, such as histone deacetylases, 
thus creating transcriptional repressor complexes (Dick, 2007; Morrison et al., 2002; Herrera 
et al., 1996). pRb is, in turn, regulated by cyclin and cyclin-dependent kinases (Cdk),which 
deactivate pRb through phosphorylation. Specifically, Cyclin D/Cdk4 and Cyclin E/Cdk2 
complexes phosphorylate pRb in the G1 phase of the cell cycle, allowing E2F-1, E2F-2 and 
E2F-3 to activate target genes (Connell-Crowley et al., 1997; Smith et al., 1996). The other 
pRb family proteins, p107 and p130, generally bind to E2F-4 and E2F-5, and function to 
modulate their nucleocytoplasmic shuttling during different periods of the cell cycle. 
Specifically, E2F-4 and E2F-5 translocate into the nucleus outside of the G1 and S-phases, 
and act as transcriptional repressors in complexes containing p107 and p130 (Ginsberg et al., 
1994; Moberg et al., 1996) (Hijmans et al., 1995) (Guo et al., 2009). 
5.2 DP proteins 
Optimal binding of E2F to DNA requires cooperative interactions with a member of the 
other subfamily of E2F proteins, the DP  (Dimerization Partner) family. In fact, with the 
exception of E2F-7 and -8, all functional E2F complexes identified contain a member of the 
E2F family associated with a DP protein.  The DP family is composed of three known 
members, DP-1 (with isoforms DP-1α and DP-1β), DP-2  (and its mouse orthologue DP-3), 
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and DP-4 (Helin and Harlow, 1994; Milton et al., 2006; Ormondroyd et al., 1995). Different 
DP proteins have distinct modulatory effects on E2F. For example, DP-1β can mediate E2F 
translocation to the nucleus, whereas DP-1α, which shows reduced affinity for E2F, 
participates in E2F nuclear export and translocation to the cytoplasm. In this manner, DP-1α 
indirectly represses the ability of E2F-1 to activate transcription (Ishida et al., 2005). DP-4 can 
mediate transcriptional repression as well (Milton et al., 2006). Furthermore, a growing body 
of evidence shows that other proteins that interact with DP factors, such as C/EBP, TRIP-Br 
and SOCS3, can modulate E2F activation of gene transcription (Masuhiro et al., 2008; 
Zaragoza et al., 2010).  
5.3 C/EBP  
CCAAT/Enhancer Binding Protein (C/EBP) factors are generally characterized as effectors 
of cellular growth arrest. Within the C/EBP family, C/EBPα has been shown to associate 
with and repress E2F-1 (Wang et al., 2007). This interaction has been demonstrated through 
co-immunoprecipitation assays and is independent of pRb family proteins. Rather, it 
requires the presence of DP-1 or DP-2  (Zaragoza et al., 2010).  
The effect of C/EBP repression on E2F activity has been demonstrated in multiple tissues. In 
primary murine keratinocytes, C/EBPα and β are upregulated as these cells differentiate 
and move from the basal to the suprabasal layers of the epidermis. Further, the repression of 
E2F target genes via the action C/EBP is necessary for proper differentiation (Lopez et al., 
2009). Interactions between C/EBP and E2F also play important roles during senescence. 
Indeed, C/EBPα and HDAC1 are recruited to hepatic DNA from older, but not young, mice 
(Wang et al., 2008). Recruitment of these two factors is accompanied by decreased 
transcription of E2F target genes.  
In mouse 3T3-L1 preadipocytes, C/EBPα, but not C/EBPβ, disrupts E2F-p107 and induces 
E2F-p130 complexes, leading to decreased proliferation, likely involved in preadipocyte 
differentiation (Timchenko et al., 1999).  
In mouse hepatocytes devoid of C/EBPβ, E2F target genes are repressed and DNA synthesis 
is severely impaired. In these cells, C/EBP β interacts with E2F-1, facilitating recruitment of 
CBP and p300 to E2F target genes. The recruitment of these multiprotein complexes results 
in upregulation of E2F targets involved in cell proliferation (Wang et al., 2007). C/EBPβ  
is also required for expression of E2F-3 and S-phase progression in uterine epithelial cells 
(Ramathal et al., 2010). In primary epidermal keratinocytes, C/EBPα interferes with  
DNA synthesis in response to DNA damage (Johnson, 2005). However, the mechanisms 
involved are not fully undertood. It has been proposed that C/EBPα functions with 
E2F/pRb complexes to repress transcription of S-phase genes.  In neuroblastoma cells, 
C/EBP is involved in induction of apoptotic gene transcription by E2F-1 (Marabese et  
al., 2003). 
5.4 SOCS3 
The Suppressor of Cytokine Signaling (SOCS) family of proteins act as negative feedback 
regulators of the JAK-STAT pathway. Recently, SOCS factors have also been shown to 
associate with DP-1 and DP-3. SOCS3 inhibits transcriptional activation of E2F target genes 
and cell cycle progression. The mechanisms involved in this repression include SOCS3 
inhibition of E2F/DP dimerization, thus preventing the formation of the E2F DNA-binding 







The Transcriptional Regulator Interacting with the PHD zinc finger and/or the 
Bromodomain-1 (TRIP-Br1) protein (also known as p34) is a transcriptional modulator that 
directly interacts with DP-1, as well as with the co-activators p300/CBP and KRIP1(Hsu et 
al., 2001). As such, TRIP-Br co-activates E2F responsive genes, such as B-myb, in U2OS 
osteosarcoma cells, an ability potentiated by KRIP1. This effect is impaired by pRb. TRIP-Br1 
also interferes with deactivation of Cyclin D/Cdk4 complex by p16INK4, effectively 
activating E2F by inhibiting pRb (Sim et al., 2004). 
5.6 p110 CUX1 
Cut homeobox 1 (CUX1) proteins are transcription factors that can either activate or repress 
transcription. In particular, the CUX1 isoform p110 can stably interact with DNA and 
promote entry into the S-phase of the cell cycle (Truscott et al., 2008). P110 CUX1 interacts 
with E2F-1 or E2F-2,  stimulating their recruitment to the DNA polymerase α gene 
promoter, in a manner that requires ability of E2F to bind DNA. Further, common targets 
for E2F and p110 CUX1 include genes involved in cell cycle progression, DNA repair and 
replication (Truscott et al., 2008).  
5.7 YY1 
The transcriptional repressor YY1 can bind to target sites adjacent to E2F binding elements 
in the promoters of genes such as Cdc6 (Schlisio et al., 2002). In addition, the YY1 accessory 
protein Ring1 and YY1 binding protein (RYBP) can interact with E2F-2, -3 and -4 to 
synergistically enhance binding of E2F-2 and -3 (but not of E2F-1). In this manner, YY1 and 
RYBP not only enhance the binding and transcription of E2F to certain promoters, but also 
add specificity. 
5.8 TFE3 
Studies of the p68 promoter have shown that transcription factor E3 (TFE3) operates in a 
similar manner to YY1. Thus, the E Box bound by TFE3 and the E2F consensus sequence 
occur in close proximity in the p68 promoter. TFE3 and E2F-3 bind to those sites 
cooperatively (Giangrande et al., 2003; Giangrande et al., 2004). This interaction requires 
E2F-3, but not TFE3 binding to DNA. Although a direct interaction between these two 
proteins was not be demonstrated, these two factors likely work together in a larger protein 
complex, or interact temporarily to recruit one another to the p68 promoter. 
6. Regulation of E2F activity by viral oncoproteins 
Viruses work by hijacking the cellular machinery of their host cell, to facilitate their 
replication. Hence, it is not surprising that constitutive activation of E2F, which induces cell 
transition into a state of DNA replication (S-phase), is a critical step in the viral modification 
of infected cell functions. 
6.1 Human papillomavirus protein E7 
The human papillomaviruses (HPV) are commonly known oncoviruses. This notoriety is 
due to their ability to activate E2F proteins, causing rapid and unregulated progression 
through the cell cycle (Lee et al., 1998). HPV couples this action with deactivation of 
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pathways that act as fail-safe mechanisms for E2F activity, such as p53-mediated apoptosis 
(Moody and Laimins, 2010). The key HPV viral protein involved in activating E2Fs is E7. 
This protein carries an LXCXE domain characteristic of proteins that associate with pRb 
family proteins (Lee et al., 1998).  In this manner, E7 proteins bind to pRb, p107 and p130, 
dissociating them from E2F factors. The mechanisms involved in this effect include blockade 
by E7 of the pRb-E2F binding domain (Lee et al., 1998).  As a result, E2F species bind to and 
activate target genes without the possibility of repression. E7 also induces pRb proteasomal 
degradation, by increasing its ubiquitination (Moody and Laimins). Furthermore, there is 
evidence to indicate that E7 also binds to p300/CBP, allowing this acetyltransferase to 
facilitate and rapidly increase the transcription of E2F target genes (Bernat et al., 2003). 
6.2 SV40 large-T antigen 
The simian virus 40 (SV40) genome encodes a protein that shares some characteristics with 
HPV E7, termed large T-antigen. Similar to HPV E7, large-T antigen has a LXCXE domain, 
which can bind all three pRb family proteins, leading to release of free E2F and expression 
of its target genes (DeCaprio, 2009). In addition, large-T antigen binds preferentially to the 
hypophosphorylated form of pRb, present during the G1-phase of the cell cycle (Ludlow et 
al., 1989). The characterization of the interactions between large-T antigen and complexes 
containing p130 or p107 and E2F-4 has been central to understanding the mechanisms 
involved in deactivation of pRb family proteins by this viral factor (Sullivan et al., 2000). 
Dissociation of p107 or p130 from E2F also requires Large-T antigen interactions with the J 
type of chaperone protein Hsc70 and ATP.   
Similar to HPV E7, large-T antigen binds to p300/CBP through its C-terminus (Eckner et al., 
1996). This interaction is likely involved in histone acetylation and transcriptional activation 
of E2F target genes. Significantly, mutations in the C-termimus of large-T antigen impair its 
ability to bind p300/CBP, but are without effect on its capacity to disrupt pRb binding to 
E2F (Nemethova et al., 2004).  
6.3 Adenovirus E1A 
Adenovirus protein E1A functions in a similar manner to HPV E7 and SV40 large-T antigen. 
E1A interacts with multiple cellular proteins, including the pRb family and p300/CBP 
(Raychaudhuri, 1991; Liu, 2007). X-ray crystallographic characterization of E1A has revealed 
that its N-terminal domain competes with the transactivation domain of E2F for binding to 
pRb. This induces a decrease in E2F binding to pRb by competition (Liu, 2007). Similar to 
other viral oncoproteins, E1A also has an LXCXE domain that binds to pRb, p107 and p130 
(Dyson, 1992). E1A also binds the 400-kDa protein p400, which mediates further interactions 
with TRRAP/PAF400, along with the DNA helicase TAP54α/β). Together, these proteins 
form a chromatin remodeling complex, which contributes to cell transformation and 
activation of E2F target genes that mediate viral DNA replication (Liu, 2007). 
6.4 Human parvovirus NS1 
Human parvovirus B19 (B19V) is the only pathogenic human parvovirus, and it targets cells 
of the erythroid lineage, expecially erythroid progenitors (Wan et al., 2010). The B19V 
protein NS1 (nonstructural protein 1) interacts with E2F-4 and E2F-5, inducing their nuclear 
accumulation and G2 arrest, necessary for viral replication (Wan et al., 2010). 






transcriptional repression of genes necessary for the G2/M transition.  Thus, B19V targets 
cells for arrest in the G2 phase by altering E2F activity, indicating the importance of this 
family of transcription factors in all phases of the cell cycle and multiple aspects of cell cycle 
progression and DNA replication and repair. 
7. Conclusions 
A large body of work has been focused on identifying  the mechanisms that regulate E2F 
activity and its consequences on induction of DNA repair. As a result, it has become 
apparent that E2F activity is complex, and is regulated at multiple levels, including 
transcription, post-translational modifications and protein-protein interactions. However, 
understanding of how different post-translational modifications modulate E2F interactions 
with other proteins, allowing it to form transcriptional activator or repressor complexes is in 
its infancy.  
The biological roles of the various modes of E2F modulation go well beyond normal 
development and cell differentiation, implicate mechanisms of DNA repair as a central 
function, and are involved in the genesis of multiple pathologies.  
Although pRb family proteins form the central backbone of E2F regulation, they are only 
one component. Studies of HPV proteins have shown that, in addition to E7, the proteins E5 
and E6 are critical for the functional transformation of a cell. In the case of HPV, these 
proteins serve to deactivate the p53 pathway, preventing the pro-apoptotic responses 
normally switched on with abnormal activation of E2F. Other viruses encode proteins that 
serve a similar function. The identification and study of these proteins may provide key 
insights into the function of these viruses and the pathways that regulate E2F  during 
normal tissue development and homeostasis, and affect DNA repair mechanisms to ensure 
viral replication. 
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